ப்ராஜெக்ட் நவம்பர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராஜெக்ட் நவம்பர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராஜெக்ட் நவம்பர் Today - Breaking & Trending Today

Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain


Share:
Solensia is the first injectable monoclonal antibody (mAb) licensed for alleviation of pain associated with osteoarthritis (OA) in cats
Solensia works as a monthly treatment targeting Nerve Growth Factor (NGF), a key player in OA pain
European Commission Marketing Authorization for a similar product in dogs, Librela
®,
was received in November 2020
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia
® (frunevetmab), a new feline osteoarthritis treatment to alleviate pain. Osteoarthritis in cats is a very prevalent condition
1, existing in 40% of cats, and may generate pain and limit a cat s comfort and quality of life if not treated. ....

Catherine Knupp , Margarete Gruen , Mike Mcfarland , Rob Kelly , Clin Pharmacokinet , Zoetis Veterinarian Market Research , European Commission Marketing Authorization , European Commission , Zoetis Inc , International Operations At Zoetis , Nerve Growth Factor , Commission Marketing Authorization , Executive Vice President , Assistant Professor , Behavioral Medicine , North Carolina State University , Chief Medical Officer , International Operations , Looking Statements , Annual Report , Factors That May Affect Future , Quarterly Reports , Current Reports , Veterinarian Market Research , Project November , கேத்தரின் க்னுபப் ,